PLx Pharma IPO: Consider Holding Off

We remain cautious on the PLx Pharma IPO and suggest investors consider holding off, given the weak IPO market, lack of commercial revenue, and small syndicate.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.